INTERNATIONAL PATENT: ACT225 BIOTHERAPEUTICS CORPORATION FILES APPLICATION FOR "METHODS OF TREATING CANCER WITH COMBINATION THERAPY COMPRISING ANTI-NECTIN-4 RADIOIMMUNOCONJUGATE AND PD-1/PD-L1 INHIBITORS"

GENEVA, March 15 -- ACT225 BIOTHERAPEUTICS CORPORATION (210 Mahabir CourtSaskatoon, Saskatchewan S7W 0J5) filed a patent application (PCT/CA2025/051176) for "METHODS OF TREATING CANCER WITH COMBINATION THERAPY COMPRISING ANTI-NECTIN-4 RADIOIMMUNOCONJUGATE AND PD-1/PD-L1 INHIBITORS" on Sep 05, 2025. With publication no. WO/2026/050866, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): UPPALAPATI, Maruti Chandra (430 Boykowich St.Saskatoon, Saskatchewan S7W 0S6), FONGE, Humphrey (210 Mahabir CourtSaskatoon, Saskatchewan S7W 0...